Regulation of KATP Channels and Na+/K+ ATPase in Relation to Fatigue Development
Condition:   Type 2 Diabetes Mellitus Intervention:   Drug: Placebo, Nicorandil, Glimepiride Sponsor:   University of Copenhagen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 14, 2018 Category: Research Source Type: clinical trials

Regulation of KATP Channels and Na+/K+ ATPase in Relation to Fatigue Development
Condition:   Type 2 Diabetes Mellitus Intervention:   Drug: Placebo, Nicorandil, Glimepiride Sponsor:   University of Copenhagen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 14, 2018 Category: Research Source Type: clinical trials